Mark Jeranko, D.O. practises rheumatology in Loveland, CO. Mark is a 2015 graduate of Kansas City University of Physicians and Surgeons.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
Dr. Jeranko is a rheumatology in Loveland, CO. This is the primary taxonomy recorded against the NPI in the federal registry, listed there as “RHEUMATOLOGY”.
NPI registry
Dr. Jeranko is listed at 2500 ROCKY MOUNTAIN AVE STE 2200, Loveland, CO 80538. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (970) 652-2333. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Dr. Jeranko's National Provider Identifier is 1114304573. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Dr. Jeranko attended Kansas City University of Physicians and Surgeons, graduating in 2015. This comes from the CMS National Downloadable File.
CMS public data
Dr. Jeranko has 11 years experience. Calculated from a graduation year of 2015, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Dr. Jeranko provides treatments such as administration of chemotherapy into vein, 1 hour or less and administration of chemotherapy into vein, each additional hour, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Jeranko. If this is you, claiming it is free.
Guide.md
Source: NPPES NPI Registry
2500 ROCKY MOUNTAIN AVE STE 2200
Loveland, CO 80538
23,456 services · 493 patients · 16 distinct codes
| Procedure | Type | Code | Services |
|---|---|---|---|
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
126 |
| Administration of chemotherapy into vein, each additional hour | Treatment | 96415 |
103 |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
55 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Treatment | 96365 |
12 |
| Injection, tocilizumab, 1 mg | Drug given | J3262 |
16,080 |
| Injection, golimumab, 1 mg, for intravenous use | Drug given | J1602 |
2,710 |
| Injection, infliximab, excludes biosimilar, 10 mg | Drug given | J1745 |
2,660 |
| Injection, denosumab, 1 mg | Drug given | J0897 |
840 |
| Injection, cetirizine hydrochloride, 0.5 mg | Drug given | J1201 |
480 |
| Injection, methylprednisolone sodium succinate, 5 mg | Drug given | J2919 |
122 |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Connections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
Other providers in the same specialty who trained at the same institution.
Providers who graduated from the same medical school in the same year.
Providers in CO who bill this service to Medicare most often.
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.